Is IGC Pharma, Inc. IGC stock halal to invest in?

Yes, as of August 2026, IGC Pharma, Inc. stock (IGC) is classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. IGC Pharma, Inc. currently passes all four AAOIFI financial screens: non-permissible income remains below 5% of total revenue, interest-bearing investments and interest-bearing debt each remain below 30% of market capitalisation, and the company has no impermissible preference share structure. The stock's current purification factor is 100%. Compliance is reassessed every month as updated screening data arrives, and a stock's status can change when new financial reports are released. You can always check the current status of IGC Pharma, Inc. and explore other Shariah compliant stocks in the Tabadulat app.

How often is IGC Pharma, Inc. IGC reviewed for Shariah compliance?

Tabadulat reviews IGC Pharma, Inc. IGC for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for IGC Pharma, Inc. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does IGC Pharma, Inc. IGC pass the AAOIFI Non Permissible Income criteria?

Yes, as of August 2026, IGC Pharma, Inc. stock (IGC) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. IGC Pharma, Inc.'s income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does IGC Pharma, Inc. IGC pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of August 2026, IGC Pharma, Inc. stock (IGC) passes the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. This limit ensures shareholders are not materially profiting from riba (interest). IGC Pharma, Inc.'s interest-bearing investments are currently within the 30% threshold. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does IGC Pharma, Inc. IGC pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of August 2026, IGC Pharma, Inc. stock (IGC) passes the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. This cap limits shareholders' exposure to interest-based leverage. IGC Pharma, Inc.'s interest-bearing debt is currently within the 30% threshold. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for IGC Pharma, Inc. IGC stock?

As of August 2026, the dividend purification factor for IGC Pharma, Inc. (IGC) is 100%. Purification (tazkiyah) is the practice of donating to charity the portion of dividend income attributable to incidental non-permissible sources, typically interest earned on a company's cash, and AAOIFI methodology requires it even for fully compliant stocks. The purification factor is the figure halal investors use to work out that donation on IGC Pharma, Inc. dividends. It is recalculated with each monthly screening as new financial data arrives, and the Tabadulat app can help you calculate and track purification across your whole portfolio.

Does IGC Pharma, Inc. IGC pass the AAOIFI Preference Share screen?

Yes, as of August 2026, IGC Pharma, Inc. stock (IGC) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. IGC Pharma, Inc. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

English

العربية

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

IGC Pharma, Inc.

NYSE

Shariah-Compliant

Not Shariah

IGC

About

IGC Pharma, Inc.

IGC

IGC Pharma Inc. is a pharmaceutical and biotechnology company focused on the development and commercialization of innovative therapies for the treatment of chronic pain, cancer, and other life-altering conditions. The company's primary role involves leveraging unique approaches to drug development, particularly using cannabinoids, to create novel solutions that address unmet medical needs. IGC Pharma operates within the biotech sector, which is marked by significant research and development activities and a robust pipeline of products at various stages of clinical trials. Notably, IGC Pharma's initiatives in the pharmaceutical industry aim at integrating traditional pharmaceutical methods with new advancements in cannabinoid science. This positions the company as a potential influencer in sectors such as pain management and oncology, where treatment options are continually evolving. Due to its focus on strategic research and development, IGC Pharma plays a crucial role in the broader biotechnology market, aiming to introduce cutting-edge therapies that can change the standard of care for complex medical conditions.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://igcpharma.com

IGC

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Trade Now

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

IGC Pharma, Inc.

About

IGC Pharma, Inc.

IGC

Frequently asked questions

Is IGC Pharma, Inc. IGC stock halal to invest in?

How often is IGC Pharma, Inc. IGC reviewed for Shariah compliance?

Does IGC Pharma, Inc. IGC pass the AAOIFI Non Permissible Income criteria?

Does IGC Pharma, Inc. IGC pass the AAOIFI Interest Bearing Investments criteria?

Does IGC Pharma, Inc. IGC pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for IGC Pharma, Inc. IGC stock?

Does IGC Pharma, Inc. IGC pass the AAOIFI Preference Share screen?

How do I buy IGC Pharma (IGC) stock?

Open your account.

Deposit.

Screen.